NEW YORK, NY / ACCESSWIRE / October 4, 2017 / All three of the U.S. major indexes reached new records for the second consecutive session as recent economic data continues to support a healthy U.S. economy. The Dow Jones Industrial Average gained 0.37 percent to close at 22,641.67, its fifth consecutive daily gain, while the S&P 500 Index rose 0.22 percent to close at 2,534.58. The tech-heavy NASDAQ Composite Index rose 0.23 percent to close at 6,531.71. On Tuesday, Ford, General Motors and Toyota all reported better-than-expected sales in September.

"We're seeing moves into economically sensitive stocks, which is an indication that investors believe some of the favorable economic data that's coming out," said Bucky Hellwig, Senior Vice President at BB&T Wealth Management in Birmingham, Alabama, according to Reuters.

RDI Initiates Coverage on:

Anthera Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=ANTH

NewLink Genetics Corporation
https://rdinvesting.com/news/?ticker=NLNK

Anthera Pharmaceuticals Inc.'s stock jumped 32.87% Tuesday, to close the day at $1.90. The stock recorded a trading volume of 3,426,365 shares, which was above its three months average volume of 297,925 shares. In the last year Anthera Pharmaceuticals Inc.'s shares have traded in a range of 1.20 - 27.36. The share price has gained 58.33% from its 52 week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $1.38 is greater than its 200-day moving average of $1.34. Shares of Anthera Pharmaceuticals have fallen approximately 63.41 percent year-to-date.

Access RDI's Anthera Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ANTH

On Tuesday, shares of NewLink Genetics Corporation recorded a trading volume of 2,849,278 shares, which was above the three months average volume of 2,274,760 shares. The stock ended the day 5.00% higher at 10.91. The share price has gained 84.92% from its 52 week low with a 52 week trading range of 5.90 - 25.17.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $9.60 is below its 200-day moving average of $11.95. Shares of NewLink Genetics have gained approximately 6.13 percent year-to-date.

Access RDI's NewLink Genetics Corporation Research Report at:
https://rdinvesting.com/news/?ticker=NLNK

Our Actionable Research on Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) and NewLink Genetics Corporation (NASDAQ: NLNK) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com